Skip to search formSkip to main contentSkip to account menu

Paroxetine mesylate

Known as: (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Mesylate, Paroxetine Methanesulfonate, Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-,(3S,4R)-, Methanesulfonate 
The mesylate salt form of paroxetine, a phenylpiperidine derivative and a selective serotonin reuptake inhibitor (SSRI) with antidepressant and… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Brisdelle
ParoxetineParoxetine mesylate 40 MG Oral Tablet [Pexeva]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PEXEVA® Brand of (paroxetine mesylate) tablets Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children…
  • 2014
  • Corpus ID: 53525189
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents… 
2013
2013
Pharmaceutical approval update.
Canagliflozin (Invokana) for type-2 diabetes; denosumab (Xgeva) for giant-cell tumor of bone; and paroxetine mesylate (Brisdelle… 
2000
2000
Pharmaceutical compositions for oral administration, comprising paroxetine methanesulfonate.
1999
1999
paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
1999
1999
Paroxetine methanesulfonate in crystalline form, pharmaceutical composition containing it and the use of any of the compound to f
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)